Location History:
- Croix, FR (2017)
- Crox, FR (2020)
Company Filing History:
3 out of 4 
2 out of 1,745 
1 out of 13 Years Active: 2017-2020
Title: Stéphane Burlet: Innovator in Neurodegenerative Disease Treatment
Introduction
Stéphane Burlet is a notable inventor based in Crox, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of neurodegenerative diseases. With a total of 3 patents to his name, Burlet's work is recognized for its innovative approach to complex medical challenges.
Latest Patents
Stéphane Burlet's latest patents focus on sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine. These patents detail the preparation and use of these compounds, which are essential in developing pharmaceutical compositions aimed at treating neurodegenerative diseases. The inventions highlight the importance of these sulphate salts and their pharmaceutically acceptable solvates in advancing medical treatments.
Career Highlights
Throughout his career, Stéphane Burlet has worked with prominent organizations such as Alzprotect and the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale). His experience in these institutions has allowed him to contribute significantly to research and development in the pharmaceutical sector.
Collaborations
Stéphane Burlet has collaborated with various professionals in his field, including Cécilia Estrella and Mathieu Barrier. These partnerships have fostered innovation and have been instrumental in the advancement of his research.
Conclusion
Stéphane Burlet's contributions to the field of pharmaceuticals, particularly in neurodegenerative disease treatment, underscore his role as an influential inventor. His patents and collaborations reflect a commitment to improving healthcare through innovative solutions.